Cargando…
Covid-19 Vaccine Effectiveness in New York State
BACKGROUND: Population-based data from the United States on the effectiveness of the three coronavirus disease 2019 (Covid-19) vaccines currently authorized by the Food and Drug Administration are limited. Whether declines in effectiveness are due to waning immunity, the B.1.617.2 (delta) variant of...
Autores principales: | Rosenberg, Eli S., Dorabawila, Vajeera, Easton, Delia, Bauer, Ursula E., Kumar, Jessica, Hoen, Rebecca, Hoefer, Dina, Wu, Meng, Lutterloh, Emily, Conroy, Mary Beth, Greene, Danielle, Zucker, Howard A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Massachusetts Medical Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693697/ https://www.ncbi.nlm.nih.gov/pubmed/34942067 http://dx.doi.org/10.1056/NEJMoa2116063 |
Ejemplares similares
-
New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status — New York, May 3–July 25, 2021
por: Rosenberg, Eli S., et al.
Publicado: (2021) -
New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status — New York, May 3–July 25, 2021
por: Rosenberg, Eli S., et al.
Publicado: (2021) -
Comparison of COVID-19 home-testers vs. laboratory-testers in New York State (excluding New York City), November 2021 to April 2022
por: Dorabawila, Vajeera, et al.
Publicado: (2023) -
COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status
and Previous COVID-19 Diagnosis — California and New York,
May–November 2021
por: León, Tomás M., et al.
Publicado: (2022) -
Contact tracing: Characteristics of COVID-19 cases that provided contacts
por: Dorabawila, Vajeera, et al.
Publicado: (2023)